Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CUE Cue Biopharma, Inc.

盘前交易 09-15 04:55:51 EDT

30.55

+1.81

+6.30%

最高31.10	最低28.24	成交量13.66万
今开28.24	昨收28.74	日振幅9.95%
总市值2.22亿	流通市值2.09亿	总股本726.44万
成交额415.76万	换手率2.00%	流通股本684.53万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CUE","market":"US","secType":"STK","nameCN":"Cue Biopharma, Inc.","latestPrice":30.55,"timestamp":1789416000000,"preClose":28.74,"halted":0,"volume":136595,"delay":0,"changeRate":0.06297842727905367,"floatShares":6845300,"shares":7264400,"eps":-29.46,"marketStatus":"盘前交易","change":1.81,"latestTime":"09-15 04:55:51 EDT","open":28.24,"high":31.1,"low":28.24,"amount":4157643.0953,"amplitude":0.099513,"askPrice":33.16,"askSize":100,"bidPrice":12.22,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-29.46,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1514869200000,"exchange":"NASDAQ","adjPreClose":30.55,"postHourTrading":{"tag":"盘后","latestPrice":30.55,"preClose":30.55,"latestTime":"19:58 EDT","volume":1503,"amount":45916.65,"timestamp":1789430314888,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9099478397793384,"impliedVol":0.8827,"impliedVolPercentile":0.8224},"requestUrl":"/m/hq/s/CUE/wiki","defaultTab":"wiki","newsList":[{"id":"1132587001","title":"Cue Biopharma 股东拟转售至多1,505,570股普通股——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1132587001","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132587001?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:16","pubTimestamp":1786565772,"startTime":"0","endTime":"0","summary":"Cue Biopharma, Inc.（简称Cue Biopharma）近期向美国证券交易委员会（SEC）提交了一份文件。该文件显示，部分现有股东计划进行股份转售。具体来看，这些股东拟出售的普通股数量上限为1,505,570股。此举旨在通过二级市场实现股份流动性的释放。相关申请已按规定程序递交至监管机构，等待后续处理。市场对此反应尚不明朗，投资者可关注后续进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111225802","title":"Cue Biopharma任命Dominic Borie博士为首席医疗官兼研发负责人","url":"https://stock-news.laohu8.com/highlight/detail?id=1111225802","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111225802?lang=zh_cn&edition=full","pubTime":"2026-07-13 20:31","pubTimestamp":1783945881,"startTime":"0","endTime":"0","summary":"Cue Biopharma, Inc. 宣布了一项重要人事任命，Dominic Borie博士已正式加入公司，担任首席医疗官兼研究与开发负责人。Borie博士在生物制药领域拥有深厚的专业知识和丰富的管理经验，他的加入预计将为公司在免疫肿瘤学领域的创新药物研发带来新的动力。公司管理层表示，此次任命是加强其领导团队和推进核心产品管线战略的关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159220220","title":"Cue Biopharma宣布董事会人事变动，新增董事助力公司持续演进","url":"https://stock-news.laohu8.com/highlight/detail?id=1159220220","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159220220?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:06","pubTimestamp":1780430799,"startTime":"0","endTime":"0","summary":"Cue Biopharma宣布了其董事会的人事变动，并迎来了新董事的加入，这标志着公司在持续演进的道路上迈出了新的一步。此次调整旨在强化董事会的专业构成，以更好地支持公司未来的发展战略。随着新成员的加入，董事会将融合更多元化的视角与经验，为公司的成长注入新的活力。这一举措反映了Cue Biopharma致力于优化治理结构，以应对不断变化的市场环境并把握发展机遇。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190898661","title":"Cue Biopharma通过独家授权Ascendant Health Sciences临床阶段双机制抗IgE抗体拓展产品管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1190898661","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190898661?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:15","pubTimestamp":1777580151,"startTime":"0","endTime":"0","summary":"Cue Biopharma, Inc. 宣布与Ascendant Health Sciences Ltd.达成一项独家授权协议，获得一款临床阶段双机制抗IgE抗体的全球权益。此举标志着该公司产品管线的战略性扩展。\n该抗体药物采用创新的双重作用机制，旨在更有效地治疗由免疫球蛋白E（IgE）介导的过敏性疾病。目前，该候选药物已进入临床开发阶段，展现出潜在的治疗优势。\n通过此次授权合作，Cue Biopharma进一步丰富了其在免疫学领域的研发组合。公司计划加速推进该抗体的临床开发，为患有相关疾病的患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161132152","title":"Cue Biopharma任命Shao-Lee Lin博士为首席执行官、总裁兼董事会董事，引领公司持续增长并向临床阶段转型","url":"https://stock-news.laohu8.com/highlight/detail?id=1161132152","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161132152?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:06","pubTimestamp":1777579585,"startTime":"0","endTime":"0","summary":"Cue Biopharma, Inc.正式宣布，任命Shao-Lee Lin博士（医学博士、哲学博士）担任公司首席执行官、总裁以及董事会董事。此项重要人事任命旨在推动公司实现持续的业务增长，并顺利完成向临床阶段生物制药企业的战略转型。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186367824","title":"Cue Biopharma将获得勃林格殷格翰合作与授权协议项下750万美元临床前里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1186367824","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186367824?lang=zh_cn&edition=full","pubTime":"2026-04-08 20:00","pubTimestamp":1775649634,"startTime":"0","endTime":"0","summary":"Cue Biopharma, Inc. (以下简称Cue Biopharma) 宣布，其与勃林格殷格翰达成的合作与授权协议已达成一项重要临床前里程碑。根据协议条款，Cue Biopharma将因此获得750万美元的付款。\n该笔款项的支付标志着双方在特定药物研发项目上取得了关键进展，体现了合作关系的稳步推进。此次里程碑的达成不仅为Cue Biopharma带来了即时资金支持，也进一步验证了其技术平台在药物发现阶段的潜力。\n双方将继续推进合作项目的后续开发工作，致力于将创新疗法推向市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118128124","title":"Cue Biopharma达成临床前里程碑，预计2026年5月获750万美元付款——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1118128124","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118128124?lang=zh_cn&edition=full","pubTime":"2026-04-07 20:09","pubTimestamp":1775563760,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新文件披露，Cue Biopharma, Inc.因达成一项临床前研发里程碑，预计将于2026年5月获得750万美元的付款。这一里程碑的触发，标志着公司在特定药物研发项目上取得关键进展。该笔付款源于Cue Biopharma与合作伙伴达成的协议条款，临床前阶段的成功为后续开发奠定了坚实基础。对于专注免疫疗法开发的Cue Biopharma而言，此次资金注入将支持其持续推进创新生物制剂的研发管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616364138","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616364138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2616364138?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:33","pubTimestamp":1772462029,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时33分，Cue Biopharma, Inc.股票出现波动，股价急速上涨5.78%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Rallybio Corporation、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Xeris制药涨幅较大，Ensysce Biosciences, Inc.、Rallybio Corporation、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为74.33%、27.13%、19.78%，振幅较大的相关个股有Rallybio Corporation、Ensysce Biosciences, Inc.、Edesa Biotech, Inc.，振幅分别为15.52%、13.14%、12.27%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223349a4428e36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302223349a4428e36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518208806","title":"Cue Biopharma, Inc.盘中异动 快速下挫8.18%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518208806?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613723,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Cue Biopharma, Inc.股票出现波动，股价大幅跳水8.18%。截至发稿，该股报1.01美元/股，成交量1860股，换手率0.00%，振幅6.36%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2175.89%、425.85%、66.65%，振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进，振幅分别为100.05%、98.72%、98.49%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213523abf2fdc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213523abf2fdc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517410939","title":"Cue Biopharma, Inc.盘中异动 股价大跌5.98%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517410939?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:33","pubTimestamp":1741192408,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时33分，Cue Biopharma, Inc.股票出现异动，股价大幅跳水5.98%。截至发稿，该股报1.10美元/股，成交量5.9574万股，换手率0.09%，振幅5.09%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Radiopharm Theranostics Limited涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为910.00%、295.77%、280.58%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003328963af864&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306003328963af864&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516860878","title":"Cue Biopharma, Inc.盘中异动 早盘急速下跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516860878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516860878?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:24","pubTimestamp":1741101852,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时24分，Cue Biopharma, Inc.股票出现异动，股价大幅跳水5.00%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1174.66%、1135.75%、688.19%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd、Protagenic Therapeutics Inc C/Wts 29/04/2026 ，振幅分别为100.00%、68.71%、66.67%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232412a25f145e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304232412a25f145e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514373841","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514373841?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:46","pubTimestamp":1740753978,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时46分，Cue Biopharma, Inc.股票出现异动，股价急速下挫6.79%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Immunitybio, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为512.97%、340.10%、276.59%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.，振幅分别为45.32%、31.14%、29.25%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822461898967dd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822461898967dd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514622668","title":"Cue Biopharma, Inc.盘中异动 下午盘大幅上涨6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514622668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514622668?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:25","pubTimestamp":1740601524,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时25分，Cue Biopharma, Inc.股票出现波动，股价快速上涨6.40%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6834.47%、330.23%、264.27%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270425249893ea39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270425249893ea39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013048","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌6.93%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514013048?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:54","pubTimestamp":1740495259,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时54分，Cue Biopharma, Inc.股票出现异动，股价急速下挫6.93%。截至发稿，该股报1.18美元/股，成交量2.4041万股，换手率0.04%，振幅7.09%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为960.57%、701.50%、552.96%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Nutriband Inc C/Wts ，振幅分别为100.27%、46.65%、42.76%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225419962ff7fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225419962ff7fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514377374","title":"Cue Biopharma, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514377374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514377374?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:27","pubTimestamp":1740410844,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时27分，Cue Biopharma, Inc.股票出现波动，股价急速下跌5.30%。截至发稿，该股报1.25美元/股，成交量1.8319万股，换手率0.03%，振幅3.92%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为201.25%、84.67%、27.77%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232724a25221f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224232724a25221f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512448070","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512448070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512448070?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:54","pubTimestamp":1739987645,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时54分，Cue Biopharma, Inc.股票出现波动，股价大幅上涨5.80%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为647.10%、251.00%、218.61%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为250.83%、159.49%、52.00%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200154069628edb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200154069628edb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512198059","title":"Cue Biopharma, Inc.盘中异动 股价大跌6.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512198059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512198059?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:59","pubTimestamp":1739901545,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时59分，Cue Biopharma, Inc.股票出现异动，股价急速跳水6.04%。截至发稿，该股报1.40美元/股，成交量6.415万股，换手率0.10%，振幅7.68%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为619.16%、192.23%、162.16%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015905a24ad87e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015905a24ad87e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511157601","title":"Cue Biopharma, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511157601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511157601?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:02","pubTimestamp":1739473352,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时02分，Cue Biopharma, Inc.股票出现异动，股价大幅拉升5.20%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3160.56%、1875.88%、1225.28%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140302329621effa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502140302329621effa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510380833","title":"Cue Biopharma, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510380833?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284271,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Cue Biopharma, Inc.股票出现异动，股价快速跳水5.26%。截至发稿，该股报1.26美元/股，成交量5743股，换手率0.01%，振幅0.75%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为1878.94%、504.70%、170.12%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.，振幅分别为18.18%、14.11%、8.85%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223111abcb05ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223111abcb05ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CUE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509074059","title":"Cue Biopharma, Inc.盘中异动 股价大跌5.93%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509074059","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509074059?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:05","pubTimestamp":1738940722,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时05分，Cue Biopharma, Inc.股票出现波动，股价大幅下挫5.93%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为3348.13%、102.73%、72.25%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、46.71%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230522a23d2b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207230522a23d2b0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CUE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cuebiopharma.com","stockEarnings":[{"period":"1week","weight":0.1133},{"period":"1month","weight":-0.1067},{"period":"3month","weight":0.2788},{"period":"6month","weight":2.8515},{"period":"1year","weight":0.3733},{"period":"ytd","weight":2.3344}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cue Biopharma, Inc.于2014年12月31日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，设计了一类新型的注射疗法，以选择性地在患者体内直接参与和调节靶向的、与疾病相关的T细胞。该公司的愿景是通过生成一类新的T细胞接合剂，用于选择性调节疾病特异性T细胞，将大自然的信号或“线索”转化为蛋白质疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.050638},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.057224},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.063158},{"month":4,"riseRate":0.555556,"avgChangeRate":0.1863},{"month":5,"riseRate":0.444444,"avgChangeRate":0.054128},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.05119},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.098101},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.023458},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.022118},{"month":10,"riseRate":0.5,"avgChangeRate":0.074591},{"month":11,"riseRate":0.625,"avgChangeRate":0.074714},{"month":12,"riseRate":0.375,"avgChangeRate":-0.083168}],"exchange":"NASDAQ","name":"Cue Biopharma, Inc.","nameEN":"Cue Biopharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cue Biopharma, Inc.(CUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cue Biopharma, Inc.,CUE,Cue Biopharma, Inc.股票,Cue Biopharma, Inc.股票老虎,Cue Biopharma, Inc.股票老虎国际,Cue Biopharma, Inc.行情,Cue Biopharma, Inc.股票行情,Cue Biopharma, Inc.股价,Cue Biopharma, Inc.股市,Cue Biopharma, Inc.股票价格,Cue Biopharma, Inc.股票交易,Cue Biopharma, Inc.股票购买,Cue Biopharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cue Biopharma, Inc.(CUE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cue Biopharma, Inc.(CUE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}